Before you launch The Metabolic Reset, add the GLP-1 Microdosing Protocol patients will ask about.

 

Patients are not just asking about weight loss medication anymore.

They are asking about inflammation, insulin sensitivity, longevity, metabolic flexibility, lower-dose options, fewer side effects, and how to incorporate a GLP without feeling like the entire plan depends on appetite suppression.

The GLP-1 Microdosing Protocol utilizing the RESET™ Method gives you the clinical framework to evaluate candidates, review biomarkers, guide low-dose therapy when clinically appropriate, manage side effects, and plan tapering or long-term maintenance with more clarity.

So you are not piecing together your GLP-1 approach from pharmacy calls, patient questions, and “what are other providers doing?” energy.

You have a protocol.


What's Inside:

 

✦ The RESET™ Clinical Framework

A structured methodology for assessing GLP-1 microdosing candidates through root-cause readiness, patient education, systemic support, protocol evolution, and long-term transition planning.

✦ Lab + Biomarker Assessment Guide

A metabolic and inflammatory assessment framework that helps you evaluate glucose, insulin, HOMA-IR, hs-CRP, homocysteine, ferritin, omega-3 status, hormone patterns, thyroid function, cortisol, gut health, and liver markers before jumping into treatment.

✦ GLP-1 Microdosing Schedule

Low-and-gradual dosing guidance for semaglutide and tirzepatide, designed to support a more measured approach than aggressive weight-loss models.

✦ Clinical Decision Tree + Risk Stratification

A practical guide for determining who may be low, moderate, or higher risk based on metabolic markers, inflammation, hormone patterns, and gut/detox considerations.

✦ Hormone + Inflammation Optimization Support

Guidance for addressing the factors that can influence metabolic response, including thyroid, adrenal, sex hormone, nutrient, gut, inflammation, and mitochondrial support.

✦ Supplement + Lifestyle Protocols

Clinical support for protein intake, strength training, Zone 2 cardio, metabolic flexibility, gut support, mitochondrial health, detoxification, inflammation reduction, and long-term maintenance.

✦ SOP + SOAP Note Templates

Implementation support so your team has a clearer process for patient assessment, treatment initiation, monitoring, documentation, and follow-up.

✦ Side Effect + Tapering Guidance

Patient-facing and provider-facing guidance for managing common side effects, monitoring progress, adjusting dose, and transitioning off therapy when clinically appropriate.

Add To Cart If:

You already offer, or plan to offer, GLP-1 therapy inside your metabolic program.

You want clinical support for patients who are asking about lower-dose GLP-1 options, metabolic optimization, inflammation, or longevity.

You want a framework that looks beyond the medication and accounts for hormones, gut health, muscle preservation, nutrient status, inflammation, and long-term metabolic resilience.

You do not want to build dosing guidance, SOPs, SOAP notes, side effect handouts, tapering language, and biomarker criteria yourself.

You want your GLP-1 offer to feel more precise, more clinically grounded, and easier to document from the start.

 

Why Add It to Metabolic Reset?


Because GLP-1 therapy is no longer just a prescription conversation.

It is a clinical strategy conversation.

Patients want to know if they are a candidate, how low-dose therapy works, what labs matter, how to minimize side effects, how to preserve muscle, what happens when they stop, and how to make the results last.

The GLP-1 Microdosing Protocol gives you the framework to answer those questions with more confidence.

Not another weight loss script.

A structured protocol for metabolic precision.


🛒 Purchase Now & Get Immediate Access


Empower your patients with a smarter, safer, and more strategic way to optimize metabolism, without the side effects of aggressive weight-loss models.


This protocol is intended for licensed clinicians and healthcare practitioners for educational and informational purposes only. It is not intended as medical advice, nor does it substitute professional judgment in patient care. GLP-1 receptor agonists are not FDA-approved for non-obese individuals for metabolic optimization or longevity, and use should be based on clinical discretion, evolving research, and risk-benefit analysis. All treatments and interventions should be individualized based on patient presentation, laboratory assessments, and professional judgment.

By purchasing this protocol, you acknowledge that it is not a substitute for clinical training and that all medical decisions remain the responsibility of the prescribing provider.